Drug regulator calls for cancelling licence of firm related to Uzbek deaths

Posted on:
Key Points

Noida: The central drug regulator has recommended cancellation of the licence of Noida-based pharmaceutical firm Marion Biotech, whose cough syrup has been linked to the deaths of 18 children in Uzbekistan, after an analysis found that its products did not meet quality standards, officials from the state and the Centre said on Saturday...

Noida police on Friday arrested three officials of the Noida-based pharmaceutical firm Marion Biotech on the basis of an FIR lodged by the Central Drugs Standard Control Organization (CDSCO) in connection with an ongoing investigation that found Marions product samples adulterated and not of standard quality (REUTERS)..

We are reviewing paperwork and have initiated the process, Gautam Buddh Nagars drug inspector Vaibhav Babbar said.. Speaking on condition of anonymity, a central government official said that during investigation it was found that the firm was not following regulatory guidelines...

The FIR against the company said that central and state drug authorities checked samples of Marion Biotechs drugs during joint inspections on December 27, 29 and 30..

The government analyst of Regional Drugs Testing Laboratory, Chandigarh, vide test report CHD/LS/22-23/380 dated 14.01.2023 has declared the subject sample to be Not of Standard Quality for the reasons that the sample does not conform to claim as per Patent and Proprietary read the CDSCO letter to the company, seen by HT...

You might be interested in

Cough syrup deaths in Uzbekistan: Three employees of Noida-based pharma firm arrested

03, Mar, 23

The arrests come after an FIR was lodged late Thursday night against five officials of Marion Biotech, including two of its directors

Uzbek cough syrup deaths: DCGI issues alert against supplier of Marion Biotech

10, Mar, 23

A representative of Maya Chemtech, who spoke on condition of anonymity, said the company did not sell the raw material to Marion for pharmaceutical products, but cosmetics. | Latest News Delhi

Diabetes drug among 48 to fail quality test

06, Oct, 23

The development follows several incidents of toxic Indian-made cough syrups causing the deaths of children in other countries

Uzbekistan cough syrup deaths | Process underway to cancel license of Marion Biotech, says official

05, Mar, 23

On Friday, the local police arrested three senior employees of the firm after an FIR was lodged against them on charges of manufacturing and sale of adulterated drugs.

After prohibiting popular FDC for kids under 4, drug regulator scrutinises other cold & cough remedies

22, Jan, 24

Following December notice prohibiting combination of chlorpheniramine maleate & phenylephrine hydrochloride, CDSCO has ‘decided to rope in paediatricians to review other permitted FDCs’.

Govt: Drugmakers must ensure good manufacturing practices

07, Jan, 24

The new guidelines come against the backdrop of deaths reported in certain countries such as Gambia in Africa that were linked with consumption of Indian drugs | Latest News India

Marion Biotech: India cancels licence of drug maker linked to child deaths in Uzbekistan

23, Mar, 23

Marion Biotech's cough syrups have been linked to 18 child deaths in Uzbekistan.